Stay updated on Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-08T14:01:07.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:23:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T01:18:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed information about a phase II trial of nivolumab for HTLV-associated adult T-cell leukemia/lymphoma, which included objectives, treatment outlines, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    44%
    Check dated 2025-04-16T20:36:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 14, 2025.
    Difference
    0.7%
    Check dated 2025-04-09T14:36:17.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.6%
    Check dated 2025-04-02T00:20:45.000Z thumbnail image

Stay in the know with updates to Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for HTLV-Associated T-Cell Leukemia/Lymphoma Clinical Trial page.